Additionally, CAFs contribute to ECM restructuring through the enzymatic activity of MMPs and the RhoA–ROCK pathway, thereby generating physical conduits that facilitate tumor cell motility, invasiveness, and resistance to therapeutic agents (80, 87). The gene discussed is RHOA; the disease is neoplasm.